Insights

Gathering insights about Exact…

Similar companies to Exact

Exact Tech Stack

Exact uses 8 technology products and services including RSS, OneTrust, Salesforce, and more. Explore Exact's tech stack below.

RSS
Content Management System
OneTrust
Cookie Compliance
Salesforce
Customer Relationship Management
Twitter typeahead.js
Javascript Libraries
Windows 11
Operating Systems
Microsoft Defender
Security
YouTube
Video Players
Google Analytics 360
Web Analytics

Media & News

Exactech Comments on Impact of Hurricanes Irma and Harvey; Adjusts Q3 Earnings Guidance and Announces Q3 Earnings Call
GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, said today it is adjusting guidance for the third quarter of 2017 as a result of the impact of Hurricanes Irma and Harvey. CEO and President David Petty said the estimated US revenue impact of the two hurricanes was approximately $1.2M to sales in Q3 across Florida, Texas, Georgia and the Carolinas. “We were fortunate that our facilities were undamaged during the hurricanes. However, the storms caused our surgeon customers in the affected states to postpone scheduled surgeries, directly affecting our Q3 revenue stream. In addition, due to hurricane preparation procedures at our Gainesville and Sarasota locations, our manufacturing and shipping operations lost two days of operating capacity. As a result, domestic revenues were near the bottom of our expectations. We now expect to report approximately $61.4MM in worldwide revenue for the third quarter. We also are adjusting our EPS guidance for the quarter to $0.19-$0.21 per share, a reduction of approximately $0.04 per share from our previously issued guidance of $0.23-$0.25 per share due to the net income impact of these lower revenues as well as the impact of the operations interruption,” Petty said. The company will release its third quarter 2017 financial results on Monday, October 30, 2017. A copy of the earnings release will be available at http://www.hawkassociates.com. The company will host a conference call with CEO David Petty and key members of the management team on Tuesday, October 31 at 10:00 a.m. Eastern Time. The call will cover Exactech’s third quarter 2017 results. Mr. Petty will open the conference call and a question-and-answer session will follow. To participate in the call, dial 1-800-334-0872 any time after 9:50 a.m. Eastern on October 31. International and local callers should dial 1-719-325-4845. A live webcast of the call will be available at http://www.hawkassociates.com/profile/exac.cfm or http://public.viavid.com/index.php?id=126701. This call will be archived for approximately 90 days. About Exactech Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at http://www.exac.com and http://www.hawkassociates.com. An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert. This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.
Oct 12, 2017 | www.businesswire.com
Exactech Schedules Second Quarter 2017 Earnings Release and Conference Call
GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, hip and knee will release its second quarter 2017 financial results on Thursday, July 27, 2017. A copy of the earnings release will be available at http://www.hawkassociates.com. The company will hold a conference call with CEO David Petty and key members of the management team on Friday, July 28 at 10:00 a.m. Eastern Time. The call will cover Exactech’s second quarter 2017 results. Mr. Petty will open the conference call and a question-and-answer session will follow. To participate in the call, dial 888-417-2254 any time after 9:50 a.m. Eastern on July 28. International and local callers should dial 1-719-325-4790. A live webcast of the call will be available at http://www.hawkassociates.com/profile/exac.cfm or http://public.viavid.com/index.php?id=125497. This call will be archived for approximately 90 days. About Exactech Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech can be found at http://www.exac.com. A current investment profile on Exactech (Nasdaq: EXAC) is available online at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert. This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.
Jul 13, 2017 | www.businesswire.com
Exactech Schedules First Quarter 2017 Earnings Release and Conference Call
GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, hip and knee will release its first quarter 2017 financial results on Tuesday, April 25, 2017. A copy of the earnings release will be available at http://www.hawkassociates.com. The company will hold a conference call with CEO David Petty and key members of the management team on Wednesday, April 26 at 10:00 a.m. Eastern Time. The call will cover Exactech’s first quarter 2017 results. Mr. Petty will open the conference call and a question-and-answer session will follow. To participate in the call, dial 877-874-1569 any time after 9:50 a.m. Eastern on April 26. International and local callers should dial 719-325-4888. A live webcast of the call will be available at http://www.hawkassociates.com/profile/exac.cfm or http://public.viavid.com/index.php?id=123876. This call will be archived for approximately 90 days. About Exactech Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech can be found at http://www.exac.com. A current investment profile on Exactech (Nasdaq: EXAC) is available online at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert. This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.
Apr 12, 2017 | www.businesswire.com
Exactech Schedules Fourth Quarter and Year-End 2016 Earnings Release and Conference Call
GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, hip and knee will release its fourth quarter and year-end 2016 financial results before the market opens on Tuesday, February 21, 2017. A copy of the earnings release will be available at http://www.hawkassociates.com. The company will hold a conference call with CEO David Petty and key members of the management team on the same day, Tuesday, February 21 at 10:00 a.m. Eastern Time. The call will cover Exactech’s fourth quarter and year-end 2016 results. Petty will open the conference call and a question-and-answer session will follow. To participate in the call, dial 1-888-471-3836 any time after 9:50 a.m. Eastern on February 21. International and local callers should dial 1-719-325-2475. A live webcast of the call will be available at http://www.hawkassociates.com/profile/exac.cfm or http://public.viavid.com/index.php?id=122940. This call will be archived for approximately 90 days. About Exactech Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech can be found at http://www.exac.com. A current investment profile on Exactech (Nasdaq: EXAC) is available online at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert. This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.
Feb 13, 2017 | www.businesswire.com
Exactech Schedules Third Quarter 2016 Earnings Release and Conference Call
GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, hip, knee, and spine, will release its third quarter financial results after the market closes on Monday, October 31, 2016. A copy of the earnings release will be available at http://www.hawkassociates.com. The company will hold a conference call with CEO David Petty and key members of the management team on Tuesday, November 1 at 9:00 a.m. Eastern Time. The call will cover Exactech’s third quarter results. Petty will open the conference call and a question-and-answer session will follow. To participate in the call, dial 1-877-440-5803 any time after 8:50 a.m. Eastern on November 1. International and local callers should dial 1-719-325-4765. A live and archived webcast of the call will be available at http://www.hawkassociates.com/profile/exac.cfm or http://public.viavid.com/index.php?id=121574. This call will be archived for approximately 90 days. About Exactech Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech can be found at http://www.exac.com. A current investment profile on Exactech (Nasdaq: EXAC) is available online at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert. This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.
Oct 24, 2016 | www.businesswire.com
Exactech Schedules Second Quarter 2016 Earnings Release and Conference Call
GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, will release its second quarter financial results after the market closes on Monday, August 1, 2016. A copy of the earnings release will be available at http://www.hawkassociates.com. The company will hold a conference call with CEO David Petty and key members of the management team on Tuesday, August 2nd at 10:00 a.m. Eastern Time. The call will cover Exactech’s second quarter results. Petty will open the conference call and a question-and-answer session will follow. To participate in the call, dial 1-888-430-8709 any time after 9:50 a.m. Eastern on August 2nd. International and local callers should dial 1-719-325-2361. A live webcast of the call will be available at http://www.hawkassociates.com/profile/exac.cfm or http://public.viavid.com/index.php?id=120383. This call will be archived for approximately 90 days. About Exactech Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at http://www.exac.com and http://www.hawkassociates.com. An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert. This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.
Jul 14, 2016 | www.businesswire.com
Exactech Schedules First Quarter 2016 Earnings Release and Conference Call
GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, will release its first quarter financial results after the market closes on Tuesday, April 26th, 2016. A copy of the earnings release will be available at http://www.hawkassociates.com. The company will hold a conference call with CEO David Petty and key members of the management team on Wednesday, April 27th at 10:00 a.m. Eastern Time. The call will cover Exactech’s first quarter results. Petty will open the conference call and a question-and-answer session will follow. To participate in the call, dial 1-888-556-4997 any time after 9:50 a.m. Eastern on April 27th. International and local callers should dial 1-719-325-2464. A live webcast of the call will be available at http://www.hawkassociates.com/profile/exac.cfm or http://public.viavid.com/index.php?id=119078. This call will be archived for approximately 90 days. About Exactech Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at http://www.exac.com and http://www.hawkassociates.com. An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert. This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.
Apr 12, 2016 | www.businesswire.com

Exact's Email Address Formats

Exact uses at least 1 format(s):

Exact Email Formats	Example	Percentage
First.Last@exact.com	John.Doe@exact.com	87%
First.Middle.Last@exact.com	John.Michael.Doe@exact.com	9%
FLast@exact.com	JDoe@exact.com	3%
First.Middle@exact.com	John.Michael@exact.com	1%

Frequently Asked Questions

Where is Exact's headquarters located?

Exact's main headquarters is located at Molengraaffsingel 33 Delft, ZH 2629 JD NL. The company has employees across 6 continents, including EuropeAsiaNorth America.

What is Exact's stock symbol?

Exact is a publicly traded company; the company's stock symbol is EXAC.

What is Exact's official website and social media links?

Exact's official website is exact.com and has social profiles on LinkedIn.

How much revenue does Exact generate?

As of October 2025, Exact's annual revenue is estimated to be $513M.

What is Exact's NAICS code?

Exact's NAICS code is 5112 - Software Publishers.

How many employees does Exact have currently?

As of October 2025, Exact has approximately 2.6K employees across 6 continents, including EuropeAsiaNorth America. Key team members include Chief Executive Officer: P. R.Chief Executive Officer: M. J.Chief Customer Success Officer - Member Of The Executive Committee: M. V. D. S.. Explore Exact's employee directory with LeadIQ.

What industry does Exact belong to?

Exact operates in the Software Development industry.

What technology does Exact use?

Exact's tech stack includes RSSOneTrustSalesforceTwitter typeahead.jsWindows 11Microsoft DefenderYouTubeGoogle Analytics 360.

What is Exact's email format?

Exact's email format typically follows the pattern of First.Last@exact.com. Find more Exact email formats with LeadIQ.

When was Exact founded?

Exact was founded in 1984.

Exact

Software DevelopmentZuid-Holland, Netherlands1001-5000 Employees

Exact develops cloud software for small and medium-sized companies and their accountants. The products automate business processes in areas such as Finance and HR, and provide specific ERP solutions for wholesale distribution, manufacturing, business services, and construction. This saves time and provides insight. It enables customers to work efficiently, make informed decisions, and continue growing. More than 675,000 companies primarily in the Netherlands, Belgium and Germany already rely on Exact's software.  

 

Exact was founded in 1984 in Delft, the Netherlands, which is still the location of our head office. Every day, more than 2,000 ambitious professionals work on innovation. Driving responsible business, with respect for each other, the environment and society is central to this. For more information, visit www.exact.com.